ArticleNature communications2026
Flow matching for reaction pathway generation.
Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Elucidating reaction mechanisms requires efficient generation of transition states (TSs) and products. Existing diffusion and sequence-based models accelerate parts of this process over traditional string-based methods, but typically still require manual enumeration of either TSs or products, and stochastic diffusion dynamics can be inefficient and hard to control. We introduce MolGEN, a conditional flow-matching framework that uses deterministic optimal transport to map Gaussian priors to chemical distributions. For TS generation, MolGEN improves TS geometry and barrier-height prediction over diffusion models while enabling sub-second sampling. For reaction product generation, it achieves competitive top-k accuracy while preserving mass and electron balance. Using the same backbone for TS and product sampling, MolGEN enables template-free generative exploration of reaction networks without the repeated quantum-chemistry searches required by prior methods. For the γ-ketohydroperoxide decomposition network, it produces more valid TSs than string-based methods using only 12 quantum-chemistry evaluations instead of 1156, and identifies a lower-barrier pathway.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.